Our system also uses the options market in order to receive additional signals on current sentiments. The stock's open price was 0.18.Salarius Pharmaceuticals has 48 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Salarius Pharmaceuticals' mailing address is 2450 Holcombe Blvd. Suite X, Houston TX, 77021. The official website for the company is www.salariuspharma.com. The company can be reached via phone at (832) 834-6992 or via email at jeremy@lifesciadvisors.com. Get the latest Salarius Pharmaceuticals, Inc. (SLRX) stock news and headlines to help you in your trading and investing decisions. The stock was also green in the previous trading session and went high by 8.52% at closing. Industry Pharmaceuticals. According to analysts' consensus price target of $4.00, Salarius Pharmaceuticals has a forecasted upside of 1,580.7% from its current price of $0.24. Salarius Pharmaceuticals is an emerging biotechnology company developing targeted therapies to treat pediatric and other cancers, including advanced solid tumors. Their SLRX share price forecasts range from $4.00 to $4.00. On average, they predict the company's stock price to reach $4.00 in the next year. This suggests a possible upside of 1,532.0% from the stock's current price. View analysts price targets for SLRX or view top-rated stocks among Wall Street analysts. Houston, Texas 77021. Rooms Rankings Earnings Newsletters Shop. Salarius Pharmaceuticals Inc 0.24 0.00 (1.33%) Watch. About Salarius Pharmaceuticals Salarius Pharmaceuticals, LLC is a clinical-stage oncology company targeting the epigenetic causes of cancers and is developing treatments for patients that need them the most. Click Here to get the full Stock Report for Salarius Pharmaceuticals Inc stock. Sector Health Care/Life Sciences. SLRX stock price saw a push of 7.45% to reach $1.01 a share at the time of this writing. Shares of SLRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Salarius Pharmaceuticals' stock price today? Disclaimer: This content is intended for informational purposes. Over the past year the S&P 500 is up 16.46% while SLRX has fallen -65.19%. A high-level overview of Salarius Pharmaceuticals, Inc. (SLRX) stock. Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) stock closed at 0.2451 per share at the end of the most recent trading day (a 11.41 % change compared to the prior day closing price) with a volume of 1.96M shares and market capitalization of 13.75M.Is a component of indices and it is traded on NASDAQ exchange. We are developing two classes of drugs that address gene dysregulation: epigenetic drugs and targeted protein degraders. No Comments. SLRX receives a SLRX rating from InvestorsObserver's Stock Sentiment Indicator. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. The stock was also green in the previous trading session and went high by 8.52% at closing. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. August 25, 2021. Salarius Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022. View our SLRX earnings forecast. How were Salarius Pharmaceuticals' earnings last quarter? Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX) posted its quarterly earnings results on Friday, August, 5th. We reckon the fact that Salarius Pharmaceuticals managed to shrink its cash burn by 30% over the last year is rather encouraging. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. 12:40 PM. Investors are responding positively to Salarius Pharmaceuticals announcing the successful completion of its pre-IND (Investigational New Drug) meeting process with the U.S. Food and Drug Administration (FDA) for SP-3164. In the last year Salarius Pharmaceuticals saw its revenue grow by 51%. In certain cancers, the proteins that regulate gene expression become dysregulated and incorrectly turn genes on or off, which can lead to disease development and progression. We reckon the fact that Salarius Pharmaceuticals managed to shrink its cash burn by 30% over the last year is rather encouraging. Salarius Pharmaceuticals is trading at 0.19 as of the 4th of August 2022; that is 5.56 percent increase since the beginning of the trading day. Cancel. Shares of the Salarius Pharmaceuticals, Inc. (SLRX) stock were soaring in the pre-market today on August 25, 2021. Salarius Pharmaceuticals Inc. 2450 Holcombe Boulevard. Salarius Pharmaceuticals ( NASDAQ: SLRX) shares dipped ~28% Friday morning after the biopharmaceutical company announced a $2.3M securities offering. The company belongs in the Biotechnology industry, At the very opening of the session, the stock price was $0.23 and reached a high price of $0.2594, prior to closing the session it reached the value of $0.22. Salarius Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical need. Salarius Pharmaceuticals Inc. (SLRX) is priced at $0.25 after the most recent trading session. SLRX stock price saw a push of 7.45% to reach $1.01 a share at the time of this writing. Revenue also improved during the period, increasing by 9.5%. The stock price of Salarius Pharmaceuticals Inc (NASDAQ: SLRX) increased by over 29% during intraday trading today. Salarius Pharmaceuticals Inc. [SLRX] stock Initiated by Ladenburg Thalmann analyst, price target now $3.80. Log In. S&P 500 0.00%. The all-time high Salarius Pharmaceuticals stock closing price was 604.25 on April 21, 2015.; The Salarius Pharmaceuticals 52-week high stock price is 1.20, which is 566.7% above the current The stock price of Salarius Pharmaceuticals Inc (NASDAQ: SLRX) increased by over 20% pre-market. that Salarius Pharmaceuticals's share price could reach $4.00 by Mar 11, 2023. Shares of the Salarius Pharmaceuticals, Inc. (SLRX) stock were soaring in the pre-market today on August 25, 2021. As of June 17, 2022, Salarius Pharmaceuticals Inc had a $10.7 million market capitalization, compared to the Biotechnology & Medical Research median of $104.4 million, Salarius Pharmaceuticals Incs stock is down 59.6% in 2022, down 2.8% in the previous five trading days and down 80.6% in the past year. The stock touched a low price of $0.2151.Recen Company. SLRX has fallen -$0.15 from the previous closing price of $1.17 on volume of 799,590 shares. This is why. dbtnews 2022-04-29. Get the latest Salarius Pharmaceuticals Inc (SLRX) real-time quote, historical performance, charts, and other financial information to help you make Phone Number 346-772-0346. Phone 1 346 770-0346. Real-time trade and investing ideas on Salarius Pharmaceuticals Inc SLRX from the largest community of traders and investors. Overall market sentiment has been neutral on Salarius Pharmaceuticals Inc stock lately. Salarius Pharmaceuticals - SLRX News Headlines $0.24 0.00 (0.00%) (As of 08/12/2022 12:00 AM ET) Today's Range $0.23 $0.24 50-Day Range $0.17 $0.25 52-Week Range $0.16 $1.20 Volume 298,591 shs Average Volume 762,461 shs Market Capitalization $13.36 million P/E Ratio N/A Dividend Yield N/A Price Target $4.00 Profile Analyst Ratings Chart In addition, the Company is also developing treatments for cancers caused by dysregulated gene expression. Before making any investment, you should do your own analysis. DOW 0.00%. The average Salarius Pharmaceuticals stock price prediction forecasts a potential upside of from the current SLRX share price of $0.19. Trending now. Investors are responding positively to what was revealed in a Form 4 filing. Shares of Dicerna Pharmaceuticals ( DRNA) fell more than 11% today for no apparent reason. The latest closing stock price for Salarius Pharmaceuticals as of August 03, 2022 is 0.18.. The Wall Street analyst predicted. What are analysts forecasts for Salarius Pharmaceuticals stock? Muhammad Ali. Salarius Pharmaceuticals Inc (SLRX) stock has fallen -12.83% while the S&P 500 has gained 1.64% as of 11:46 AM on Thursday, Jan 28. Suite J-608. Revenue also improved during the period, increasing by 9.5%. NASDAQ 0.00%. Amount of Analyst Coverage Salarius Pharmaceuticals has received no research coverage in the past 90 days. Sign Up. See Top Rated MarketRank Stocks Here About Salarius Pharmaceuticals (NASDAQ:SLRX) Stock That's stonking growth even when compared to other loss-making stocks. Historical daily share price chart and data for Salarius Pharmaceuticals since 2022 adjusted for splits.
How Is Pomegranate Oil Made, How Many Households Can Meet Outside, What Is The Volcano In Santorini Called, Where Does Cameron Seely Live, How To Dye Yarn White, Why Are Corgis So Hard To Find, What Is The Best Material For A Pickleball Paddle,
why did salarius pharmaceuticals stock drop